| 000 | 01392 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517073607.0 | ||
| 264 | 0 | _c20160628 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1468-2044 | ||
| 024 | 7 |
_a10.1136/archdischild-2015-309934 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmin, Nadia Laila | |
| 245 | 0 | 0 |
_aQUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia? _h[electronic resource] |
| 260 |
_bArchives of disease in childhood _cMar 2016 |
||
| 300 |
_a287-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAlendronate _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 | _aPamidronate |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aRisedronic Acid _xadverse effects |
| 700 | 1 | _aJames, Rebecca M | |
| 700 | 1 | _aPhillips, Robert | |
| 773 | 0 |
_tArchives of disease in childhood _gvol. 101 _gno. 3 _gp. 287-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/archdischild-2015-309934 _zAvailable from publisher's website |
| 999 |
_c25632028 _d25632028 |
||